FRANKLIN STREET ADVISORS INC /NC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 172 filers reported holding PDL BIOPHARMA INC in Q2 2017. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
FRANKLIN STREET ADVISORS INC /NC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$53,000
+12.8%
20,0000.0%0.01%0.0%
Q2 2018$47,000
-20.3%
20,0000.0%0.01%
-22.2%
Q1 2018$59,000
+7.3%
20,0000.0%0.01%
+12.5%
Q4 2017$55,000
-27.6%
20,000
-11.1%
0.01%
-33.3%
Q3 2017$76,000
+35.7%
22,5000.0%0.01%
+20.0%
Q2 2017$56,000
+9.8%
22,5000.0%0.01%
+11.1%
Q1 2017$51,000
+6.2%
22,5000.0%0.01%
+12.5%
Q4 2016$48,000
-36.0%
22,5000.0%0.01%
-42.9%
Q3 2016$75,000
-36.4%
22,500
-40.0%
0.01%
-36.4%
Q2 2016$118,000
-11.3%
37,500
-6.2%
0.02%
-15.4%
Q1 2016$133,0000.0%40,000
+6.7%
0.03%0.0%
Q4 2015$133,000
-29.6%
37,5000.0%0.03%
-29.7%
Q3 2015$189,000
-21.6%
37,5000.0%0.04%
-14.0%
Q2 2015$241,000
-8.7%
37,5000.0%0.04%
-10.4%
Q1 2015$264,000
-8.7%
37,5000.0%0.05%
-12.7%
Q4 2014$289,000
+3.2%
37,5000.0%0.06%
+3.8%
Q3 2014$280,000
-22.9%
37,5000.0%0.05%
-23.2%
Q2 2014$363,000
+16.3%
37,5000.0%0.07%
+11.3%
Q1 2014$312,000
-1.3%
37,5000.0%0.06%
-3.1%
Q4 2013$316,000
+5.7%
37,5000.0%0.06%
-4.5%
Q3 2013$299,000
+3.5%
37,5000.0%0.07%
-5.6%
Q2 2013$289,00037,5000.07%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2017
NameSharesValueWeighting ↓
SMH CAPITAL ADVISORS INC 81,713$176,0000.39%
BRANDES INVESTMENT PARTNERS, LP 5,465,156$11,805,0000.30%
Crestline Management, LP 875,000$1,890,0000.30%
West Family Investments, Inc. 539,450$1,165,0000.29%
WEBER ALAN W 200,000$432,000,0000.19%
Zebra Capital Management LLC 73,910$160,0000.18%
RBF Capital, LLC 569,323$1,230,0000.14%
Leap Investments LP 69,496$150,0000.08%
Connor, Clark & Lunn Investment Management Ltd. 4,387,038$9,476,0000.06%
CHICAGO EQUITY PARTNERS LLC 519,315$1,122,0000.05%
View complete list of PDL BIOPHARMA INC shareholders